Peroxisome proliferator activated receptor-γ, leptin and tumor necrosis factor-α mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 2, 1999, Pages 92-98

  Bastard, Jean Philippe ^a   Hainque, Bernard ^a   Dusserre, Eric ^b   Bruckert, Eric ^a   Robin, Danielle ^c   Vallier, Paulette ^b   Perche, Stéphanie ^b   Robin, Pierre ^c   Turpin, Gérard ^a   Jardel, Claude ^a   Laville, Martine ^b   Forest, Claude ^c   Vidal, Hubert ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Adipose tissue; Leptin; PPAR ; TNF ; Very low calorie diet

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; INSULIN SENSITIVITY; LIPOPROTEIN METABOLISM; LOW CALORY DIET; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

EID: 0033026888     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1520-7560(199903/04)15:2<92::aid-dmrr21>3.0.co;2-4     Document Type: Article

References (46)

1. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1997; 337: 396-407.
2. Wadden T, Stunkard A, Brownell K. Very low calorie diets: their efficacy, safety and future. Ann Intern Med 1983; 99: 675-684.
3. Stich V, Harant I, de Glisezinski I, et al. Adipose tissue lipolysis and hormone-sensitive lipase expression during very-low-calorie diet in obese female identical twins. J Clin Endocrinol Metab 1996; 82: 739-744.
4. Flier JS. The adipocyte: storage depot or node on the energy information surperhighway? Cell 1995; 80: 15-18.
5. Zhang Y, Proenca R, Maffei M, Barone, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
6. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1: 1155-1161.
7. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
8. Vidal H, Auboeuf D, De Vos P, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 1996; 98: 251-255.
9. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
10. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effect of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
11. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
12. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
13. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
14. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
15. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
16. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycaemic control in patients with NIDDM. Diabetes 1996; 45: 881-885.
17. Frittitta L, Youngren JF, Sbraccia P, et al. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 1997; 40: 282-289.
18. Kellerer M, Rett K, Renn W, Groop L, Häring HU. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996; 28: 737-743.
19. Prins JB, Niesler CU, Winterford CM, et al. Tumor necrosis factor-α induces apoptosis of human adipose cells. Diabetes 1997; 46: 1939-1944.
20. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM. TNFα-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression. Endocrinology 1997; 138: 2776-2783.
21. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor Cell 1994; 79: 1147-1156.
22. Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptor and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996; 1302: 93-109.
23. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47; 507-514.
24. Auboeuf D, Rieusset J, Fajas I., et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans. No alteration in adipose tissue of obese and NIDDM patients. Diabetes 1997; 46: 1319-1327.
25. De Vos P, Lefebvre AM, Miller SG, et al. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 1996; 98: 1004-1009.
26. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997; 99: 2416-2422.
27. Klein S, Luu K, Gasic S, Green A. Effect of weight loss on whole body and cellular lipid metabolism in severely obese humans. Am J Physiol 1996; 33: E739-E745.
28. Bastard JP, Cuevas J, Cohen S, Jardel C, Hainque B. Percutaneous adipose tissue biopsy by mini-liposuction for metabolic studies. JPEN Parenter Enter 1994; 18: 466-468.
29. Fruchart JC, Beucler I, Blaton V. et al. Méthode sélectionnée pour le dosage du cholestérol des lipoprotéines non précipitables par le phosphotungstate de sodium en presence de chlorure de magnésium. Inf Scient Biol 1982; 8: 69-72.
30. Duncan MH, Singh BM, Wise PH, Carter G, Allaghband-Zadeh JA. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
31. Auboeuf D, Vidal H. The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 1997; 245: 141-148.
32. Zimmermann K, Mannhalter JW. Technical aspects of quantitative competitive PCR. Biotechniques 1996; 21: 268-279.
33. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-729.
34. De Groote D, Zangerle PF, Gevaert Y, et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239-248.
35. Clapham JC, Smith SA, Moore GBT, et al. Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans. Int J Obesity 1997; 21: 179-183.
36. Ranganathan S, Maffei M, Kern PA. Adipose tissue ob mRNA expression in humans: discordance with plasma leptin and relationship with adipose tissue TNFα expression. J Lipid Res 1998; 39: 724-730.
37. Montague CT, Prins JB, Sanders L, et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998; 47: 1384-1391.
38. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grundfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1 and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 1992; 130: 10-16.
39. Saladin R, De Vos P, Guerre-Millo M, et al. Transient increase in obese gene expression after food intake and insulin administration. Nature 1995; 377: 527-529.
40. Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 1997; 132: 237-243.
41. Acton SL, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518-520.
42. Jimenez JG, Fong B, Julien P, Despres JP, Rotstein L, Angel A. Effect of massive obesity on low and high density lipoprotein binding to human adipocyte plasma membranes. Int J Obesity 1989; 13: 699-709.
43. Stanton LA, van de Venter M, Litthauer D, Oelofsen W. Effect of lipoproteins on the differentiation of 3T3-L1 and human preadipocytes in cell culture. Comp Biochem Physiol 1997; 116B: 65-73.
44. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994; 77: 53-62.
45. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996; 10: 1096-1107.
46. Kim JB, Sarraf P, Wright M, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 1998; 101: 1-9.